Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Mol

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 27, 1976
[Letter: Glafenin and nephrotoxicity]F Maesen, M J Mol
The Netherlands Journal of Medicine|June 1, 1990
Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresisM J Mol, A F Stalenhoef
Lancet (London, England)|February 17, 1990
Adrenocortical function in patients on simvastatinM J Mol, A F Stalenhoef
Journal of Lipid Research|April 1, 1996
Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptorR K Tangirala, M J Mol, D Steinberg
Nederlands Tijdschrift Voor Geneeskunde|February 18, 1989
[Efficacy and safety of simvastatin, a new cholesterol-lowering drug]M J Mol, P M Stuyt, A F Stalenhoef
The American Journal of Medicine|October 16, 1989
Efficacy and tolerability of simvastatin (MK-733)A F Stalenhoef, M J Mol, P M Stuyt
Arthritis and Rheumatism|June 1, 1986
Chondrosarcoma coexistent with dermatomyositisM J Mol, A F Stalenhoef, A M Boerbooms
The Biochemical Journal|December 15, 1990
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiolP N Demacker, M J Mol, A F Stalenhoef
Lancet (London, England)|December 12, 1992
ACE inhibitors and LDL-apheresis with dextran sulphate adsorptionA A Kroon, M J Mol, A F Stalenhoef
The Netherlands Journal of Medicine|August 1, 1993
The role of modification of lipoproteins and of the immune system in early atherogenesisM J Mol, P N Demacker, A F Stalenhoef
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|March 27, 1976
[Letter: Glafenin and nephrotoxicity]F Maesen, M J Mol
The Netherlands Journal of Medicine|June 1, 1990
Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresisM J Mol, A F Stalenhoef
Lancet (London, England)|February 17, 1990
Adrenocortical function in patients on simvastatinM J Mol, A F Stalenhoef
Journal of Lipid Research|April 1, 1996
Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptorR K Tangirala, M J Mol, D Steinberg
Nederlands Tijdschrift Voor Geneeskunde|February 18, 1989
[Efficacy and safety of simvastatin, a new cholesterol-lowering drug]M J Mol, P M Stuyt, A F Stalenhoef
The American Journal of Medicine|October 16, 1989
Efficacy and tolerability of simvastatin (MK-733)A F Stalenhoef, M J Mol, P M Stuyt
Arthritis and Rheumatism|June 1, 1986
Chondrosarcoma coexistent with dermatomyositisM J Mol, A F Stalenhoef, A M Boerbooms
The Biochemical Journal|December 15, 1990
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiolP N Demacker, M J Mol, A F Stalenhoef
Lancet (London, England)|December 12, 1992
ACE inhibitors and LDL-apheresis with dextran sulphate adsorptionA A Kroon, M J Mol, A F Stalenhoef
The Netherlands Journal of Medicine|August 1, 1993
The role of modification of lipoproteins and of the immune system in early atherogenesisM J Mol, P N Demacker, A F Stalenhoef
Pageof 4